September 11th and 12th, 2017 saw over 5,000 delegates arrive in Manchester for the NHS England 2017 Expo. Representatives from industry, academia, and public health attended lectures, open university courses, and workshops all geared toward defining and refining the outlook of NHS practice. As a horizon scanning team dedicated to identifying the potential impact of technologies within the NHS, NIHRIO attended the conference to learn more about these upcoming changes to our healthcare system.
Given our work with digital analytics and search functions, the discussions surrounding the NHS as a digital exemplar and the launch of its Digital Academy were of particular interest. This Digital Academy will be led by a collaboration between Imperial College London, Harvard Medical School, and the University of Edinburgh, and is intended to provide NHS staff with several digital masterclasses in leadership. A pledge from the Rt Hon Jeremy Hunt MP, Secretary of State for Health, also emphasised the upcoming digital landscape of the NHS as patients will soon have access to both their medical records and general practitioners through a digital app.
In his keynote address, Simon Stevens, Chief Executive of NHS England, touched upon the availability of biological treatments for patients. According to his address, the NHS aims to have 90% of new patients receiving the best value biological within three months of a biosimilar launch, with 80% of existing patients, if clinically appropriate, to make that transition within a year. If these changes for biologic treatments are implemented correctly, they may allow for a savings of £300 million over the next several years. That savings, in turn, can be reinvested in new and innovative technologies to improve NHS care and practice.
For more information see: https://www.england.nhs.uk/expo/